Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
7.17
-0.27 (-3.63%)
At close: Oct 30, 2026, 4:00 PM EDT
7.45
+0.28 (3.91%)
After-hours: Oct 30, 2026, 7:43 PM EDT
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $384.53 million as of October 30, 2026. It is the 16,163rd most valuable company in the world and the 2,928th biggest in the United States. Its market cap has increased by 62.04% in one year.
Market Cap
384.53M
Enterprise Value
-15.51M
1-Year Change
62.04%
Global Rank
Country Rank
#2,928 United States
Category
ChartMarket Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $384.53M, an increase of 1,014.57%. That is a compound annual growth rate of 24.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 384.50M | 16.76% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 407.68M |
| Autolus Therapeutics | 404.57M |
| Prelude Therapeutics | 399.62M |
| Altimmune | 396.82M |
| ProKidney | 391.51M |
| Zura Bio | 389.15M |
| Tectonic Therapeutic | 386.69M |
| Relmada Therapeutics | 381.88M |